Molecular Devices, a Danaher company, and STEMCELL Technologies have announced a validated automated workflow designed for human intestinal organoid culture. This workflow utilizes STEMCELL's IntestiCult™ Plus Organoid Growth Medium in conjunction with the Molecular Devices CellXpress.ai Automated Cell Culture System.
The introduction of this automated workflow is significant as it enhances the efficiency and reliability of culturing human intestinal organoids, which are crucial for various research applications in life sciences. By integrating advanced automation, researchers can expect improved consistency and reproducibility in their experiments.
Looking ahead, the collaboration between Molecular Devices and STEMCELL Technologies may lead to further innovations in automated laboratory workflows. No further timeline was disclosed at the time of publication.
Editor's Note
The integration of automation in life sciences is transforming laboratory workflows, enabling researchers to achieve higher efficiency and accuracy. As organizations like Molecular Devices and STEMCELL Technologies continue to innovate, the potential for enhanced research capabilities in organoid culture and other applications will likely expand, impacting the broader field of biomedical research.
Leave a comment